ketoconazole has been researched along with bms-790052 in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agarwal, G; Banerjee, M; Bommakanti, A; Borhade, P; Das, AK; Dash, A; Dhayagude, U; Goswami, A; Gote, G; Gundu, J; Joshi, AA; Kamboj, RK; Kuldharan, S; Kumar, H; Loriya, R; Mallurwar, S; Mehta, M; Modi, D; Modi, F; Narasimham, L; Nigade, P; Palle, VP; Patil, V; Ramdas, V; Sharma, S; Singh, M; Sivaram, A; Srivastava, P; Talwar, R; Walke, DS | 1 |
| Amblard, F; Bobeck, DR; Coats, SJ; McBrayer, TR; Schinazi, RF; Shi, J; Tao, S; Tharnish, PM; Whitaker, T; Zhang, H; Zhou, L | 1 |
| Amblard, F; Bobeck, DR; Chavre, S; Coats, SJ; McBrayer, TR; Nettles, JH; Schinazi, RF; Shi, J; Tharnish, P; Whitaker, T; Zhang, H; Zhou, L | 1 |
| Bhatt, S; Dogra, A; Gour, A; Kotwal, P; Magotra, A; Nandi, U; Sharma, A; Singh, G; Wazir, P | 1 |
4 other study(ies) available for ketoconazole and bms-790052
| Article | Year |
|---|---|
Discovery and Characterization of Potent Pan-Genotypic HCV NS5A Inhibitors Containing Novel Tricyclic Central Core Leading to Clinical Candidate.
Topics: Antiviral Agents; Genotype; Hepacivirus; Molecular Structure; Structure-Activity Relationship; Viral Nonstructural Proteins | 2019 |
Synthesis and evaluation of novel potent HCV NS5A inhibitors.
Topics: Antiviral Agents; Cell Line, Tumor; Cell Survival; Hepacivirus; Humans; Microsomes, Liver; Molecular Structure; Structure-Activity Relationship | 2012 |
Synthesis and evaluation of non-dimeric HCV NS5A inhibitors.
Topics: Animals; Antiviral Agents; Carbamates; Cell Line; Chlorocebus aethiops; Dose-Response Relationship, Drug; Hepacivirus; Humans; Imidazoles; Microbial Sensitivity Tests; Molecular Structure; Pyrrolidines; Structure-Activity Relationship; Valine; Vero Cells; Viral Nonstructural Proteins; Virus Replication | 2013 |
Intervention of curcumin on oral pharmacokinetics of daclatasvir in rat: A possible risk for long-term use.
Topics: Administration, Oral; Animals; Antiviral Agents; Carbamates; Curcumin; Drug Interactions; Imidazoles; Ketoconazole; Male; Pyrrolidines; Quinidine; Rats; Rats, Wistar; Valine | 2018 |